Search

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2306-7381/9/12/663 The objective of this investigation was to determine the ovarian response, fertility, and prolificacy of nulliparous sheep when compared to multiparous sheep after a short-term (7 days) CIDR/eCG treatment which was administered during the non-breeding season. All the multiparous sheep, whereas only 54% of the nulliparous ewes, showed signs of estrus. However, 81.8% of the multiparous sheep and 100% of the nulliparous ewes ovulated. Fertility was also low after short-term progesterone treatments during the anestrous season in maiden sheep (30.8 vs. 72.7% in multiparous ewes). Such results indicate significant differences in the response to CIDR/eCG protocols for induction and synchronization of estrus and ovulation between nulliparous and multiparous sheep during the non-breeding season.

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/1424-8247/15/3/328 Este artículo pertenece al número especial "Advances in Ocular Pharmacology". Retinitis pigmentosa (RP) is an inherited eye disorder which triggers a cascade of retinal disorders leading to photoreceptor cell death and for which there is currently no effective treatment. The purpose of this research was to study whether ocular administration of a solution of progesterone (PG) in -cyclodextrins (CD) could delay photoreceptor cell death and counteract the gliosis process in an animal model of RP (rds mice). The possible effect of PG reaching the contralateral eye through the circulatory system was also evaluated. Finally, this research discusses and evaluates the diffusion of the drug from possible topical formulations for ocular administration of PG. A group of rds mice received one drop of a solution of PG in CD every 12 h for 10 days to the left eye, while the right eye was left untreated. Another group of rds mice (control) received the drug vehicle (PBS) on the left eye and, again, the right eye was left untreated. Once the treatment was finished on postnatal day 21, the animals were euthanized and histological immunofluorescence studies (TUNEL, GFAP, and DAPI staining) were carried out. Our results showed that the administration of a solution of PG in CD (CD-PG) as drops significantly decreased cell death and inflammation in the retina of the PG-treated eyes of rds mice. No effect was seen in the contralateral eye from PG that may have entered systemic circulation. In conclusion, CD-PG applied topically as drops to the eye decreases photoreceptor cell death in the early stages of RP, delaying vision loss and decreasing gliosis.

Esta tesis doctoral pertenece al Programa en Medicina Traslacional de CEINDO - CEU Escuela Internacional de Doctorado. Contiene 3 artículos: 1. Alambiaga-Caravaca, A.M., Domenech-Monsell, I.M., Sebastián-Morelló, M., Miranda, M., Balaguer-Fernández, C., Calatayud-Pascual, A., Rodilla, V., López-Castellano, A. (2021). HPLC-UV analytical validation of a method for quantification of progesterone in ex vivo trans-corneal and trans-scleral diffusion studies. Journal of Pharmaceutical and Biomedical Analysis, vol. 193, art. 113749. 2. Alambiaga-Caravaca, A.M., Calatayud-Pascual, M.A., Rodilla, V., Concheiro, A., López-Castellano, A., Álvarez-Lorenzo, C. (2020). Micelles of progesterone for topical eye administration: interspecies and intertissues differences in ex vivo ocular permeability. Pharmaceutics, vol. 12, pp. 1?18. 3. Alambiaga-Caravaca, A.M., Domenech-Monsell, I.M., Sebastián-Morelló, M., Calatayud-Pascual, Merino, V., Rodilla, V., López-Castellano, A. (2021). Development, characterization, and ex vivo evaluation of an insert for the ocular administration of progesterone. International Journal of Pharmaceutics, vol. 12, art. 120921. Tesis - CEINDO - CEU Escuela Internacional de Doctorado, Universidad CEU Cardenal Herrera (Valencia), Facultad de Ciencias de la Salud, Departamento de Farmacia, leída el 08-04-2022.

Progesterone (PG) may provide protection to the retina during retinitis pigmentosa, but its topical ocular supply is hampered by PG poor aqueous solubility and low ocular bioavailability. The development of efficient topical ocular forms must face up to two relevant challenges: Protective barriers of the eyes and lack of validated ex vivo tests to predict drug permeability. The aims of this study were: (i) To design micelles using Pluronic F68 and Soluplus copolymers to overcome PG solubility and permeability, and (ii) to compare drug diffusion through the cornea and sclera of three animal species (rabbit, porcine, and bovine) to investigate interspecies differences. Micelles of Pluronic F68 (3&ndash, 4 nm) and Soluplus (52&ndash, 59 nm) increased PG solubility by one and two orders of magnitude, respectively and exhibited nearly a 100% encapsulation efficiency. Soluplus systems showed in situ gelling capability in contrast to the low viscosity Pluronic F68 micelles. The formulations successfully passed the hen&rsquo, s egg-chorioallantoic membrane test (HET-CAM) test. PG penetration through rabbit cornea and sclera was faster than through porcine or bovine cornea, although the differences were also formulation-dependent. Porcine tissues showed intermediate permeability between rabbit and bovine. Soluplus micelles allowed greater PG accumulation in cornea and sclera whereas Pluronic F68 promoted a faster penetration of lower PG doses.

Este artículo se ha publicado de forma definitiva en: https://www.mdpi.com/2076-3921/8/3/53 Este artículo pertenece al número especial "Antioxidants and Retinal Disease". Oxidative stress has been documented to be a key factor in the cause and progression of different retinal diseases. Oxidative cellular unbalance triggers a sequence of reactions which prompt cell degeneration and retinal dysfunction, both hallmarks of several retinal pathologies. There is no effective treatment, yet, for many retinal diseases. Antioxidant treatment have been pointed out to be an encouraging palliative treatment; the beneficial effects documented involve slowing the progression of the disease, a reduction of cell degeneration, and improvement of retinal functions. There is a vast information corpus on antioxidant candidates. In this review, we expose three of the main antioxidant treatments, selected for their promising results that has been reported to date. Recently, the sulforaphane, an isothiocyanate molecule, has been unveiled as a neuroprotective candidate, by its antioxidant properties. Progesterone, a neurosteroid has been proposed to be a solid and effective neuroprotective agent. Finally, the lipoic acid, an organosulfur compound, is a well-recognized antioxidant. All of them, have been tested and studied on different retinal disease models. In this review, we summarized the published results of these works, to offer a general view of the current antioxidant treatment advances, including the main effects and mechanisms described.

Este artículo se encuentra disponible en la siguiente URL: https://iovs.arvojournals.org/article.aspx?articleid=2743694 Esta comunicación se presentó en el ARVO Annual Meeting Abstract celebrado en Vancouver, Canadá entre el 28 de abril y el 2 de mayo de 2019.

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.sciencedirect.com/science/article/abs/pii/S0960076018305077?via%3Dihub This is the pre-peer reviewed version of the following article: Benlloch-Navarro, S., Trachsel-Moncho, L., Fernández-Carbonell, Á., Olivar, T., Soria, J.M., Almansa, I. et al. (2019). Progesterone anti-inflammatory properties in hereditary retinal degeneration. Journal of Steroid Biochemistry and Molecular Biology, vol. 189 (may), pp. 291-301, which has been published in final form at https://doi.org/10.1016/j.jsbmb.2019.01.007. Este es el pre-print del siguiente artículo: Benlloch-Navarro, S., Trachsel-Moncho, L., Fernández-Carbonell, Á., Olivar, T., Soria, J.M., Almansa, I. et al. (2019). Progesterone anti-inflammatory properties in hereditary retinal degeneration. Journal of Steroid Biochemistry and Molecular Biology, vol. 189 (may), pp. 291-301, que se ha publicado de forma definitiva en https://doi.org/10.1016/j.jsbmb.2019.01.007. The interactions between steroid gonadal hormones and the retina (a part of the visual system and the central nervous system (CNS)) have received limited attention and beneficial effects of these hormones in retinal diseases is controversial. Retinitis pigmentosa (RP) is the most common cause of retinal hereditary blindness and to date no treatment is available. However, results regarding the effects of progesterone on the progression of RP are promising. With the idea of demonstrating if the progesterone retinal protection in RP is related to its possible anti-inflammatory properties, we have administered orally progesterone to rd10 mice, an animal model of RP. We observed that progesterone decreased photoreceptors cell death, reactive gliosis and the increase in microglial cells caused by RP. We also examined the expression of neuronal and inducible nitric oxide synthase (nNOS and iNOS), the enzyme responsible for NO production. The results demonstrated a decrease in nNOS expression only in control mice treated with progesterone. Inflammation has been related with an increase in lipid peroxidation. Noticeably progesterone administration was able to diminish retinal malondialdehyde (MDA, a lipid peroxidation product) concentrations in rd10 mice. Altogether, we can conclude that progesterone could be a good therapeutic option not only in RP but also for other retinal diseases that have been associated with inflammation and lipid peroxidation. Preprint

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fphar.2018.00469/full Retinitis pigmentosa (RP) is a group of inherited retinopathies characterized by photoreceptors death. Our group has shown the positive progesterone (P4) actions on cell death progression in an experimental model of RP. In an effort to enhance the beneficial effects of P4, the aim of this study was to combine P4 treatment with an antioxidant [lipoic acid (LA)] in the rd1 mice. rd1 and control mice were treated with 100 mg/kg body weight of P4, LA, or a combination of both on postnatal day 7 (PN7), 9, and 11, and were sacrificed at PN11. The administration of LA and/or P4 diminishes cell death in rd1 retinas. The effect obtained after the combined administration of LA and P4 is higher than the one obtained with LA or P4 alone. The three treatments decreased GFAP staining, however, in the far peripheral retina, and the two treatments that offered better results were LA and LA plus P4. LA or LA plus P4 increased retinal glutathione (GSH) concentration in the rd1 mice. Although LA and P4 are able to protect photoreceptors from death in rd1 mice retinas, a better effectiveness is achieved when administering LA and P4 at the same time.

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.sciencedirect.com/science/article/abs/pii/S0378432018306626?via%3Dihub This is the pre-peer reviewed version of the following article: Martinez-Ros, P., Astiz, S., Garcia-Rosello, E., Rios-Abellan, A. & Gonzalez-Bulnes, A. (2018). Effects of short-term intravaginal progestagens on the onset and features of estrus, preovulatory LH surge and ovulation in sheep. Animal Reproduction Science, vol. 197 (oct.), pp. 317-323, which has been published in final form at https://doi.org/10.1016/j.anireprosci.2018.08.046. Este es el pre-print del siguiente artículo: Martinez-Ros, P., Astiz, S., Garcia-Rosello, E., Rios-Abellan, A. & Gonzalez-Bulnes, A. (2018). Effects of short-term intravaginal progestagens on the onset and features of estrus, preovulatory LH surge and ovulation in sheep. Animal Reproduction Science, vol. 197 (oct.), pp. 317-323, que se ha publicado de forma definitiva en https://doi.org/10.1016/j.anireprosci.2018.08.046. In the present study, there was a comparison among classical long-term progestagen (fluorogestone acetate) protocols for synchronization of estrus and ovulation (14 days; group FGA14, n = 9 ewes) and short-term protocols based on 7 days of progestagen treatment plus a dose of prostaglandin F at either insertion (PG-FGA7, n = 11) or removal (FGA7-PG, n = 12). There were no significant differences in the ovulation rate and progesterone secretion among treatments. The FGA7-PG group, however, had a similar percentage of ewes expressing estrous behavior than the group FGA14 (90.9 and 100%, respectively, with a trend for a lesser percentage in the PG-FGA7 group, 63.6%) and about 90% of the ewes in the FGA7-PG group had the preovulatory surge release of LH 8 h after the onset of estrous behavior. These features may be related to a greater number of preovulatory follicles during growing phases (P < 0.05) and a greater plasma estradiol concentration (P < 0.05) in this group than in the classical 14-day group, which suggest these are more functional preovulatory follicles. In conclusion, therefore, the use of the FGA7-PG treatment may favor efficiency of progestagen-based protocols for reproductive management. Preprint

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.publish.csiro.au/rd/RD18477 This is the pre-peer reviewed version of the following article: Gonzalez-Bulnes, A., Menchaca, A., Martin, G.B. & Martinez-Ros, P. (2020). Seventy years of progestagen treatments for management of the sheep oestrous cycle: where we are and where we should go. Reproduction, Fertility and Development, vol. 32, i. 5 (24 jan.), pp. 441-452, which has been published in final form at https://doi.org/10.1071/RD18477. Este es el pre-print del siguiente artículo: Gonzalez-Bulnes, A., Menchaca, A., Martin, G.B. & Martinez-Ros, P. (2020). Seventy years of progestagen treatments for management of the sheep oestrous cycle: where we are and where we should go. Reproduction, Fertility and Development, vol. 32, i. 5 (24 jan.), pp. 441-452, que se ha publicado de forma definitiva en https://doi.org/10.1071/RD18477. The management of the ovine estrous cycle is mainly based on the use of exogenous hormones for mimicking (progesterone and its analogues) or manipulating (prostaglandin F2α and its analogues) the activity of the corpus luteum, combined with the application of other hormones mimicking the pituitary secretion of gonadotrophins (e.g.: equine chorionic gonadotrophin, eCG). These protocols have been applied without major change for decades but, now, there are two reasons to reconsider them: i) our greatly improved knowledge of the dynamics of ovarian physiology, following the application of transrectal ultrasonography, indicates that modification of the protocols may improve the yields; ii) increasing concerns about animal health and welfare, food safety and the environmental impact of the treatments, as evidenced by public opinion and therefore market forces. Here, we offer an overview of these issues, introduce an updated protocol, and suggest ways for future improvements of the protocols. Preprint

Tesis - Universidad CEU Cardenal Herrera (Valencia), Facultad de Ciencias de la Salud, Departamento de Ciencias Biomédicas, leída el 26-06-2017.

Tesis - Universidad CEU Cardenal Herrera (Valencia), Facultad de Ciencias de la Salud, Departamento de Ciencias Biomédicas, leída el 30-03-2015.